Deal Discovery
Curated Life Sciences opportunities. Controlled access only
Qualified buyers, investors and strategic partners can review selected Life Sciences opportunities after registration, profile review and access approval.
Deal preview
Illustrative opportunities in the PMC screening format
The examples below are fictional and anonymised. They show the level of public screening information a qualified buyer can expect before confidential access is requested: transaction type, sector, geography, scale, strategic fit and next step.
View three more illustrative formats
These examples are fictional. Actual opportunities may be narrower, broader, earlier, later-stage or available only to a small qualified buyer universe.
Opportunity spectrum
What qualified buyers may see after review
Deal Discovery can cover company transactions, brand and asset routes, licensing situations, partnering opportunities, minority investments and portfolio exits. Public examples remain illustrative; live projects are matched and released selectively.
Company and platform acquisitions
Owner-led businesses, healthcare platforms, subsidiaries, divisions, carve-outs and add-on opportunities.
Brand, product and portfolio sales
Rx, OTC, consumer-health, diagnostics, medtech, specialty brands and defined asset packages.
Licensing and commercialisation routes
Regional rights, distribution, co-commercialisation, launch partnerships and strategic cooperation cases.
Growth capital and portfolio exits
Minority investments, strategic investors, financial sponsors, exit situations and platform expansion routes.
Controlled access
A clear route from public profile to confidential information
Registration opens the non-confidential opportunity view after PMC has verified the business account. Confidential information remains a separate, project-specific decision.
Business access
Create an account or sign in. PMC verifies the business identity before Deal Discovery is opened.
Review public opportunities
Assess non-confidential project profiles. The optional Matching Profile improves future curation.
Request project information
Submit a separate confidential-information request for the opportunity you wish to examine further.
Agreement and release
PMC confirms contractual coverage and releases the approved material through the protected Deal Room.
Why qualified buyers use Deal Discovery
Relevant opportunities instead of broad market noise
The platform is designed to make buyer interest actionable while protecting sellers and confidential information. It connects opportunity data, client profiles, access approval and follow-up in one route.
Better relevance through profile matching
Sector, therapeutic area, geography, stage, revenue, deal type and strategic rationale help PMC route suitable opportunities.
Structured confidential information requests
Interested buyers can request CI, move through agreement review and receive protected Deal Room access after approval.
Clear next steps after interest
PMC can guide the process toward call, additional information, NBO, LOI, further review or a documented decline.
Next step
Review selected opportunities
Use your business email to enter the correct access path. Existing users are routed to sign-in; new users start with the short registration and PMC review.
